Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug 28;12(32):5148-52.
doi: 10.3748/wjg.v12.i32.5148.

BRAF, K-ras and BAT26 mutations in colorectal polyps and stool

Ying-Min Jin  1 , Bao-Jie Li, Bo Qu, Ya-Ju Du
Affiliations

BRAF, K-ras and BAT26 mutations in colorectal polyps and stool

Ying-Min Jin et al. World J Gastroenterol. .

Abstract

Aim: To assess the feasibility of using BRAF, K-ras and BAT26 genes as stool-based molecular markers for detection of colorectal adenomas and hyperplastic polyps (HPs).

Methods: We applied PCR-SSCP and direct sequencing to detect BRAF mutations of polyps and paired stool samples. Primer-mediated restriction fragment length polymorphism (RFLP) analysis and mutant-enriched PCR were used in detection of K-ras mutations of polyp tissues and paired stool samples respectively. BAT26, a microsatellite instability marker was examined by detection of small unstable alleles in a poly (A) repeat.

Results: No genetic alterations were detected in the 36 colonoscopically normal patients in either tissues or stools. BRAF, K-ras and BAT26 mutations were found in 4 (16%), 10 (40%) and 3 (12%) of 25 adenoma tissues and among them, 75%, 80% and 100% of patients were observed to contain the same mutations in their corresponding stool samples. In HPs, mutations of BRAF and K-ras were detected in the tumor DNA of 2 (11.1%) and 8 (33.3%) of 18 patients respectively, all of whom had identical alterations in their stools. Taken together, the three genetic markers detected 15 (60%) of 25 adenomas and 8 (44.4%) of 18 HPs. The sensitivity of stool detection was 80% for adenomas and 100% for HPs with an overall specificity of 92% for adenomas and 100% for HPs.

Conclusion: BRAF, K-ras and BAT26 genes have the potential to be molecular markers for colorectal adenomas and HPs, and can be used as non-invasive screening markers for colorectal polyps.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of BRAF mutation analysis in adenoma tissues (T) and paired stool (S) samples. A: SSCP analysis; B: Direct sequencing showing the wild type BRAF; C: BRAF V599E mutation; N: normal. Arrows indicate the new band (A) and the mutation site (C).
Figure 2
Figure 2
Analysis of K-ras mutations at codon 12 (A) and codon 13 (B) in adenoma tissues (T) and paired stool (S) samples. Fragments of 157 bp indicate mutations, and fragments of 128 bp(A) or 125 bp (B) respectively represent wild-type alleles. M: 100 bp ladder marker; P: Positive control; B shows the result that a mutation at codon 13 of K-ras in stool DNA was not observed in tumor counterpart.
See this image and copyright information in PMC

References

    1. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11–25; quiz 49-50. - PubMed
    1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. - PubMed
    1. Hawkins NJ, Bariol C, Ward RL. The serrated neoplasia pathway. Pathology. 2002;34:548–555. - PubMed
    1. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862–876. - PubMed
    1. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001;93:1307–1313. - PubMed

Publication types